Search Results
May 27, 2026, 08:27 ET The American Diabetes Association Debuts the 2026 Scientific Sessions, Driving the Future of Diabetes Care
Scientific Sessions begin, this year's program reflects the depth and urgency of the work advancing diabetes research and care," said Rita Rastogi Kalyani, MD, MHS, the ADA's chief scientific and medical officer. "The research presented highlights the growing impact of diabetes and obesity, and the continued
More news about: American Diabetes Association
May 27, 2026, 08:15 ET Annals of Family Medicine: Researchers in China Examine Use of AI-Assisted Ultrasound by General Practitioners To Detect Carotid Artery Plaque
General Practitioners in Carotid Plaque Detection Using AI-Enhanced Point-of-Care Ultrasound After Systematic TrainingXiaochuan Liu, MD; Sichen Yao, BS; Hua Yang, Phd; and Zhigang Pan, PhdFunding: This study was supported by the Shanghai Municipal Health Commission Key Supported
More news about: Annals of Family Medicine
May 27, 2026, 08:06 ET Want to Stay Current on Latest in Cancer Prevention and Treatment? Free Service from NCCN Can Help
ourselves that the NCCN Guidelines are the most frequently-updated clinical practice guidelines in any area of medicine," said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN. "With 91 different guidelines presenting the very latest in evidence-based, expert consensus-driven recommendations
More news about: National Comprehensive Cancer Network
May 27, 2026, 08:06 ET Want to Stay Current on Latest in Cancer Prevention and Treatment? Free Service from NCCN Can Help
ourselves that the NCCN Guidelines are the most frequently-updated clinical practice guidelines in any area of medicine," said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN. "With 91 different guidelines presenting the very latest in evidence-based, expert consensus-driven recommendations
More news about: National Comprehensive Cancer Network
May 27, 2026, 08:04 ET TransCode Therapeutics Initiates Phase 2a Clinical Trial with TTX-MC138 in Patients with ctDNA Positive Colorectal Cancer
of the University of Minnesota and Dr. Zhaohui Jin of the Mayo Clinic Comprehensive Cancer Center. The trial is chaired by Dr. Paula Pohlmann of the MD Anderson Cancer Center.The trial leverages clinical sites currently participating and actively recruiting in QLHC's PRE‑I‑SPY platform trial.
More news about: TransCode Therapeutics, Inc.
May 27, 2026, 08:00 ET From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
and select new designs, and prioritize focused compound sets.Structure-based design, ligand-centric SAR analysis, molecular descriptors, FEP, MD simulations, ADMET prediction, and AI/ML-supported modeling can all contribute to compound prioritization. The objective is not to generate designs in
More news about: Viva Biotech
May 27, 2026, 08:00 ET From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
and select new designs, and prioritize focused compound sets.Structure-based design, ligand-centric SAR analysis, molecular descriptors, FEP, MD simulations, ADMET prediction, and AI/ML-supported modeling can all contribute to compound prioritization. The objective is not to generate designs in
More news about: Viva Biotech
May 27, 2026, 08:00 ET Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® (Taletrectinib) in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting
tolerability," said presenting author, Yasir Elamin, M.D., Associate Professor of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center. "The outcomes from TRUST-II are compelling because we see rapid and durable relief from key symptoms, as well as the preservation
More news about: Nuvation Bio Inc.
May 27, 2026, 08:00 ET It's a renter's market: 2 in 5 listings come with a deal this spring
$75,482Baltimore, MD37.7 %
More news about: Zillow
May 27, 2026, 07:36 ET "This Product Has Truly Been Such A Blessing For My Health!" Gundry MD MCT Wellness, A Fat-Burning, Energy-Boosting Solution, Ideal For National Senior Health & Fitness Day
incorporate Gundry MD MCT Wellness into their daily routine as part of a broader healthy lifestyle focused on energy, metabolism, gut health, and overall longevity.†*Gundry MD MCT Wellness Frequently Asked Questions (FAQs)How do I use Gundry MD MCT Wellness?For
More news about: Gundry MD
May 27, 2026, 07:00 ET 騰盛博藥在EASL 2026發布ENSURE II期研究最新突破性數據，進一步支持BRII‑179對實現乙肝病毒持久免疫學控制的潛在作用
II期研究最終結果會議/展示形式：最新突破性壁報（Late‑Breaker Poster）展示日期和時間：5月27日8:30至5月30日 16:00（UTC+2）摘要編號：LB26‑5012 / LBP‑040報告人：黃麗虹教授，MBChB (CUHK), MD (CUHK), FRCP (Lond, Edin), FHKCP, FHKAM (Medicine)，中國香港特別行政區香港中文大學醫學數據分析中心（MDAC）及內科學與藥物治療學系胃腸病學及肝病學教授在第72周（治療結束EOT後24周），實現HBsAg清除的20例參與者中有19例符合NA停藥標准，並進入額外的24周隨訪期；另1例參與者仍為HBeAg陽性。在隊列1-3中，elebsiran
More news about: 騰盛博藥生物科技有限公司
May 27, 2026, 07:00 ET Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States
adults with recurrent respiratory papillomatosis, is commercially available in the US GERMANTOWN, Md., May 27, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing
More news about: Precigen, Inc.
May 27, 2026, 07:00 ET Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
- May 30, 16:00 (UTC+1)Abstract Number/Identifier: LB26-5012/ LBP-040Presenter: Grace Lai-Hung Wong, MBChB (CUHK), MD (CUHK), FRCP (Lond, Edin), FHKCP, FHKAM (Medicine), Professor of Gastroenterology and Hepatology at CUHK Medical Data Analytics Centre (MDAC) and Department
More news about: Brii Biosciences Limited
May 27, 2026, 06:59 ET ASHA and Fairplay Introduce New Screen Time Resource for Families Who Have Children With Developmental Delays or Differences
Latest "Be Tech Wise" Handout Offers Practical Tips for Finding a Healthy BalanceROCKVILLE, Md., May 27, 2026 /PRNewswire/ -- Managing children's screen time is among the most frustrating aspects of modern
More news about: American Speech-Language-Hearing Association (ASHA)
May 27, 2026, 06:00 ET Wishpond Reports Q1 2026 Financial Results and Provides Update Following SalesCloser Spin-Out and Viral Loops Divestiture
"Interim Financial Statements") and management's discussion and analysis (the "MD&A") for Q1-2026, representing the three months ended March 31, 2026. Copies of the Interim Financial Statements and MD&A are available on the Company's profile on SEDAR+ at
More news about: Wishpond Technologies Ltd.
May 27, 2026, 06:00 ET BMO Financial Group Reports Second Quarter 2026 Results
www.bmo.com/investorrelations to review the 2025 Annual MD&A and audited annual consolidated financial statements, quarterly presentation materials and supplementary financial and regulatory information package.Quarterly
More news about: BMO Financial Group
May 27, 2026, 06:00 ET BMO Financial Group Reports Second Quarter 2026 Results
www.bmo.com/investorrelations to review the 2025 Annual MD&A and audited annual consolidated financial statements, quarterly presentation materials and supplementary financial and regulatory information package.Quarterly
More news about: BMO Financial Group
May 27, 2026, 05:30 ET India amongst front-runners to drive AI augmentation, demographic shifts & energy security in the APAC region: Colliers India
https://mma.prnewswire.com/media/2988617/Arpit_Mehrotra_MD_Colliers.jpgLogo: https://mma.prnewswire.com/media/2667399/Colliers_Logo.jpg
More news about: Colliers
May 27, 2026, 03:00 ET Society of Hematologic Oncology opens registration for case-based MDS/AML program ahead of SOHO 2026
speakers include:Prof. Charles Craddock, CBENaval Daver, MDCourtney D. DiNardo, MD, MSCEAmir Fathi, MDRami S. Komrokji, MDSangeetha Venugopal, MD, MSAndrew Wei, MBBS, PhDFor a full list of speakers and sessions, visit the
More news about: Society of Hematologic Oncology
May 27, 2026, 00:00 ET SEABW 2026 Closes in Bangkok as Southeast Asia's Digital Assets Move from Experimentation to Institutional Adoption
event.From Thai industry, Kaweewut Temphuwapat (CIO, SCBX / CEO, SCB 10X), Atthakrit Chimplapibul (co-founder, Bitkub), and Apinand Dabpetch (MD, Ascend Bit — blockchain subsidiary of True Money under CP Group) addressed the digital transformation of Thailand's financial infrastructure. They were
More news about: Southeast Asia Blockchain Week (SEABW)
May 26, 2026, 21:00 ET SEABW 2026 Berakhir di Bangkok saat Aset Digital Asia Tenggara Beralih dari Eksperimentasi menuju Adopsi Institusional
ini.Dari industri Thailand, Kaweewut Temphuwapat (CIO, SCBX / CEO, SCB 10X), Atthakrit Chimplapibul (co-founder Bitkub), dan Apinand Dabpetch (MD, Ascend Bit — anak perusahaan blockchain True Money di bawah CP Group) membahas transformasi digital infrastruktur keuangan Thailand. Mereka bergabung
More news about: Southeast Asia Blockchain Week (SEABW)
May 26, 2026, 21:00 ET SEABW 2026 Khép Lại Tại Bangkok Khi Tài Sản Số Đông Nam Á Chuyển Từ Giai Đoạn Thử Nghiệm Sang Ứng Dụng Ở Cấp Độ Định Chế
ngành công nghiệp Thái Lan bao gồm Kaweewut Temphuwapat (CIO, SCBX / CEO, SCB 10X), Atthakrit Chimplapibul (đồng sáng lập Bitkub), và Apinand Dabpetch (MD, Ascend Bit — công ty blockchain trực thuộc True Money của CP Group), đã thảo luận về quá trình chuyển đổi số của hạ tầng tài chính Thái Lan. Họ tham
More news about: Southeast Asia Blockchain Week (SEABW)
May 26, 2026, 19:50 ET SILVERCORP REPORTS ADJUSTED NET INCOME OF $151 MILLION, $0.69 PER SHARE, AND CASH FLOW FROM OPERATING ACTIVITIES OF $310.6 MILLION FOR FISCAL 2026
1Non-GAAP measures, please refer to MD&A section 15 for reconciliation.HIGHLIGHTS FOR FISCAL 2026Steady
More news about: Silvercorp Metals Inc.
May 26, 2026, 18:31 ET Sunlight Launches Sunlight NAD+ Rx, a Clinician-Supervised NAD+ Program Delivered Through Its Clinical Pathway
Reviewed by Dr. Angela Tran, MD, board-certified in internal and obesity medicine, Chief Medical Advisor at Sunlight.KIRKLAND, Wash., May 26, 2026 /PRNewswire/ -- Sunlight NAD+ Rx, the company's new compounded
More news about: Sunlight.com
May 26, 2026, 17:12 ET 美納里尼集團於 2026 年美國臨床腫瘤學會 (ASCO) 年會上發佈新數據
ELEGANT 研究的最新數據，探討埃拉司群作為輔助治療，用於淋巴結陽性且復發風險高的早期乳癌患者的潛力。此外，一項關於他格索芙聯合治療的第 2 期研究新數據亦獲接納發表，該療法用於治療母細胞性漿細胞樣樹突細胞腫瘤 (BPDCN) 患者。該數據將由德州大學 MD 安德森癌症中心 (The University of Texas MD Anderson Cancer Center) 癌症醫學部白血病科教授 Naveen Pemmaraju 醫學博士負責報告。 此外，Stemline 的合作夥伴 Karyopharm Therapeutics 將發表一項最新突破性口頭簡報，基於塞利尼索用於未接受過
More news about: Menarini Industrie Farmaceutiche Riunite